BlackRock Fund Advisors’s OncoSec Medical Incorporated ONCS Stock Holding History

BlackRock Fund Advisors’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$48K	Buy	176 +6	+4%	+$2.06K	﹤0.01%	3776
2016 Q3	$64K	Buy	170 +1	+0.6%	+$383	﹤0.01%	3716
2016 Q2	$61K	Sell	169 -3	-2%	-$1.26K	﹤0.01%	3783
2016 Q1	$97K	Sell	172 -11	-6%	-$4.69K	﹤0.01%	3671
2015 Q4	$96K	Buy	183 +7	+4%	+$5.26K	﹤0.01%	3743
2015 Q3	$199K	Buy	176 +20	+13%	+$26.2K	﹤0.01%	3465
2015 Q2	$218K	Buy	+156	New	+$234K	﹤0.01%	3493

Other funds holding ONCS

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

BlackRock Fund Advisors's ONCS Position: Q4 2016 in Review

BlackRock Fund Advisors increased its OncoSec Medical Incorporated (ONCS) stake by 3.5% in Q4 2016, buying an estimated $2.06K and bringing the position to 176 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #3776.

BlackRock Fund Advisors first reported a position in ONCS in Q2 2015 and has held it in 7 quarters since. The position peaked at $218K in Q2 2015. 26 funds tracked by Wall St. Rank hold ONCS as of Q4 2016.

BlackRock Fund Advisors held 176 shares of OncoSec Medical Incorporated worth $48K as of Q4 2016.
BlackRock Fund Advisors bought 6 OncoSec Medical Incorporated shares in Q4 2016, an estimated $2.06K.
OncoSec Medical Incorporated made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3776 holding.
BlackRock Fund Advisors first reported a position in OncoSec Medical Incorporated in Q2 2015 and has held it in 7 quarters since.
BlackRock Fund Advisors's OncoSec Medical Incorporated position peaked at $218K in Q2 2015.
26 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.